Validating a salmon lice vaccine candidate as a preventive measure against salmon lice at the lab-scale
Publication details
Publisher : Nofima AS
International Standard Numbers
:
Printed
:
978-82-8296-570-5
Publication type : Nofima’s reports
Series : Nofima rapportserie 32/2018
Year : 2018
Links
:
ARKIV
:
http://hdl.handle.net/11250/25...
If you have questions about the publication, you may contact Nofima’s Chief Librarian.
Kjetil Aune
Chief Librarian
kjetil.aune@nofima.no
Summary
Lepeophtheirus salmonis infections represents an important limitation to sustainable salmon farming today. Vaccines against these ectoparasites have the potential to be cost-effective means of controlling infestation and avoiding the disadvantages of chemical treatments. In this project the vaccine antigen TT-P0 potential against salmon lice was explored at lab-scale. Results showed good potential of TT-P0 vaccine in controlling these ectoparasites in 1st generation by affecting the adult female count and fecundity with greater presumptive potential effect in 2nd lice generation. This is a very important preliminary documentation of TT-P0 vaccine as preventive measure. Further validation is necessary to study long-term effectiveness.
